There was no significant difference in the median tumor marker value in 2 months after initial chemotherapy (CEA 16.8 vs. 6.9 mg/L, p = 0.39; CA19-9 19.6 vs. 15.6, p = 0.19). This evidence concerns the gene CEACAM5 and neoplasm.